NeuroMetrix (Nasdaq:NURO) shares dipped today on first-quarter results that saw losses despite year-over-year revenue growth. The Woburn, Massachusetts–based company posted losses of $958,562, or 14¢ per share, on sales of $2.3 million for the three months ended March 31, 2022, for a bottom-line slide deeper into the red on sales growth of 6.8%. NeuroMetrix’s biggest […]
Implants
Abiomed announces first Impella BTR heart pump implant
Abiomed (Nasdaq:ABMD) today announced the first patient in the world was successfully treated with its Impella Bridge-to-Recovery (BTR) as part of an early feasibility study. The first implant was performed by Dr. Duc Thinh Pham and Dr. Jane Wilcox at Northwestern Medicine Bluhm Cardiovascular Institute in Chicago. Impella BTR is a forward flow heart pump implanted […]
Study demonstrates benefits of Bioretec’s bioresorbable pediatric wrist implant
Bioretec announced today that published clinical trial results support the use of its bioresorbable ActivaPin implant. Helsinki-based Bioretec designed the ActivaPin implants for pediatric patients to treat severely displaced distal radius and forearm fractures. According to a news release, the results from the retrospective, multicenter study demonstrated that patients treated with ActivaPin has a significantly […]
Philips says CavaClear used successfully for IVC filter removal
Royal Philips (NYSE:PHG) announced today that the first patients were successfully treated with its CavaClear IVC filter removal laser sheath. Patients were treated for inferior vena cava (IVC) filter removal using CavaClear at Northwestern Medicine (Chicago) by Dr. Kush R. Desai and at Stanford Hospital (Palo Alto, California) by Dr. William T. Kuo. Amsterdam-based Philips […]
NuVasive announces positive data for its Simplify cervical disc
NuVasive (Nasdaq:NUVA) today announced data from an FDA investigational device exemption study supporting its Simplify cervical disc. San Diego-based NuVasive’s two-level FDA IDE study data was recently published in the Journal of Neurosurgery: Spine and utilized in the device’s FDA pre-market application for two-level indication approval, which NuVasive received in April 2021. The peer-reviewed publication includes […]
FDA clears dorsal spanning plate from The Orthopaedic Implant Company
The Orthopaedic Implant Company (OIC) announced today that the FDA cleared its dorsal spanning plate. Reno, Nevada-based OIC will add the plate to its trauma implant portfolio to expand the potential clinical impact of its DRPx wrist fracture plating system. According to a news release, the newly cleared product — which has now been commercially […]
ChoiceSpine launches next-gen standalone anterior lumbar interbody fusion system
ChoiceSpine announced today that it launched its next-generation Harrier standalone anterior (SA) anterior lumbar interbody fusion (ALIF) system. Knoxville, Tennessee-based ChoiceSpine designed its Harrier system as a 3D-printed, standalone, screw-based system that incorporates the company’s proprietary BioBond porous structure technology. According to a news release, the system includes four titanium, dual-threaded corticocancellous screws designed for […]
Axonics launches F15 recharge-free sacral neuromodulation system
Axonics (Nasdaq:AXNX) announced today that it launched its F15 recharge-free sacral neuromodulation (SNM) system in the U.S. Irvine, California-based Axonics received FDA approval for the F15 SNM system in March. The company designed the newly developed F15 recharge-free SNM system to feature a functional life span of over 15 years at typical stimulation parameters, with […]
Ariste Medical co-founder sees great potential for drug-coated implants and orthopedics
It’s been more than a decade since Lisa Jennings launched not one but two companies in the Great Recession. In 2020, she sold CirQuest Labs to MLM Medical Labs, where Jennings serves as chief scientific officer and managing director of U.S. operations. More recently, her pre-commercial medtech development startup, Ariste Medical, won FDA 510(k) approval for […]
Lyra Therapeutics closes $100.5M private placement
Lyra Therapeutics (Nasdaq:LYRA) announced today that it closed its previously announced private placement worth $100.5 million. The company announced last week that, in the private placement, investors had the option to purchase either shares of Lyra’s common stock at $4.22 per share or, in lieu thereof, pre-funded warrants to purchase shares of common stock with an […]
Lyra Therapeutics announces $100.5M private placement
Lyra Therapeutics (Nasdaq:LYRA) announced today that it agreed to sell securities in a private placement worth more than $100 million. The company — which develops the XTreo platform designed to enable precise, sustained, and local delivery of medications to the ear, nose and throat (ENT) passages and other diseased tissues — did not list an intended use […]